Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


Articles published in Biochemistry

Retrieve available abstracts of 16 articles:
HTML format



Single Articles


    November 2020
  1. COOMBS SE, Banjade S, Kriksunov K, Clemente N, et al
    In Vitro Effects of (+)MK-801 (dizocilpine) and Memantine on beta-Amyloid Peptides Linked to Alzheimer's Disease.
    Biochemistry. 2020 Nov 29. doi: 10.1021/acs.biochem.0c00813.
    PubMed     Abstract available


    June 2020
  2. DREGNI AJ, Duan P, Hong M
    Hydration and Dynamics of Full-Length Tau Amyloid Fibrils Investigated by Solid-State Nuclear Magnetic Resonance.
    Biochemistry. 2020;59:2237-2248.
    PubMed     Abstract available


  3. KUPSKI O, Funk LM, Sautner V, Seifert F, et al
    Hydrazides are potent transition-state analogs for glutaminyl cyclase implicated in the pathogenesis of Alzheimer's Disease.
    Biochemistry. 2020 Jun 17. doi: 10.1021/acs.biochem.0c00337.
    PubMed     Abstract available


    February 2020
  4. TRIPATHI T, Khan H
    Direct Interaction between the beta-Amyloid Core and Tau Facilitates Cross-Seeding: A Novel Target for Therapeutic Intervention.
    Biochemistry. 2020;59:341-342.
    PubMed     Abstract available


  5. CANDREVA J, Chau E, Rice ME, Kim JR, et al
    Interactions between Soluble Species of beta-Amyloid and alpha-Synuclein Promote Oligomerization while Inhibiting Fibrillization.
    Biochemistry. 2020;59:425-435.
    PubMed     Abstract available


  6. LAOS V, Bishop D, Lang CA, Marsh NM, et al
    Modulating ALS-Related Amyloidogenic TDP-43307-319 Oligomeric Aggregates with Computationally Derived Therapeutic Molecules.
    Biochemistry. 2020;59:499-508.
    PubMed     Abstract available


    January 2020
  7. YANG F, Zhang W, Jiang Y, Yin F, et al
    Targeting the Amyloid-beta Fibril Surface with a Constrained Helical Peptide Inhibitor.
    Biochemistry. 2020;59:290-296.
    PubMed     Abstract available


    October 2019
  8. NAM E, Nam G, Lim MH
    Synaptic Copper, Amyloid-beta, and Neurotransmitters in Alzheimer's Disease.
    Biochemistry. 2019 Oct 11. doi: 10.1021/acs.biochem.9b00775.
    PubMed    


    April 2018
  9. PROSDOCIMI T, Mollica L, Donini S, Semrau MS, et al
    Molecular bases of PDE4D inhibition by GEBR-library compounds for cognitive amelioration in Alzheimer's disease.
    Biochemistry. 2018 Apr 13. doi: 10.1021/acs.biochem.8b00288.
    PubMed     Abstract available


    February 2018
  10. SINGH PK, Kawasaki M, Berk-Rauch HE, Nishida G, et al
    Aminopyrimidine Class Aggregation Inhibitor Effectively Blocks Abeta-Fibrinogen Interaction and Abeta-Induced Contact System Activation.
    Biochemistry. 2018;57:1399-1409.
    PubMed     Abstract available


  11. MARIS NL, Shea D, Bleem A, Bryers JD, et al
    Chemical and Physical Variability in Structural Isomers of an l/d alpha-Sheet Peptide Designed To Inhibit Amyloidogenesis.
    Biochemistry. 2018;57:507-510.
    PubMed     Abstract available


    August 2017
  12. SUMMERS KL, Fimognari N, Hollings A, Kiernan M, et al
    A Multimodal Spectroscopic Imaging Method To Characterize the Metal and Macromolecular Content of Proteinaceous Aggregates ("Amyloid Plaques").
    Biochemistry. 2017;56:4107-4116.
    PubMed     Abstract available


    March 2017
  13. MIHAILOVIC MK, Chen A, Gonzalez-Rivera JC, Contreras LM, et al
    Defective Ribonucleoproteins, Mistakes in RNA Processing, and Diseases.
    Biochemistry. 2017;56:1367-1382.
    PubMed     Abstract available


    January 2017
  14. KANURU M, Aradhyam GK
    Chaperone-like Activity of Calnuc Prevents Amyloid Aggregation.
    Biochemistry. 2017;56:149-159.
    PubMed     Abstract available


  15. KUROCHKIN IV, Guarnera E, Wong JH, Eisenhaber F, et al
    Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides.
    Biochemistry. 2017;56:228-239.
    PubMed     Abstract available


    May 2016
  16. MONDAL T, Wang H, DeKoster GT, Baban B, et al
    ApoE: In Vitro Studies of a Small Molecule Effector.
    Biochemistry. 2016;55:2613-21.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: